Traditional Chinese medicines for non-small cell lung cancer: Therapies and mechanisms-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Traditional Chinese medicines for non-small cell lung cancer: Therapies and mechanisms

Published:2023-10 Issue:4 Volume:15 Page:509-515
ISSN:1674-6384
Container-title:Chinese Herbal Medicines
language:en
Short-container-title:Chinese Herbal Medicines

Author:

Kong Fanming,Wang Chaoran,Zhao Linlin,Liao Dongying,Wang Xiaoqun,Sun Binxu,Yang Peiying,Jia Yingjie

Publisher

Elsevier BV

Subject

Pharmacology (medical),Complementary and alternative medicine,Pharmacology

Reference71 articles.

1. Compound Kushen injection combined with platinum-based chemotherapy for stage III/IV non-small cell lung cancer: A meta-analysis of 37 RCTs following the PRISMA guidelines;Chen;Journal of Cancer,2020

2. Emerging therapeutic agents for advanced non-small cell lung cancer;Chen;Journal of Hematology & Oncology,2020

3. TCM therapies combined with chemotherapy for preventing recurrence and metastasis in postoperative II to IIIA NSCLC;Chen;Medicine,2019

4. Yang-Yin-Jie-Du Decoction overcomes gefitinib resistance in non-small cell lung cancer via down-regulation of the PI3K/Akt signalling pathway;Chen;Pharmaceutical Biology,2021

5. Ophiopogonin B alleviates cisplatin resistance of lung cancer cells by inducing Caspase-1/GSDMD dependent pyroptosis;Cheng;Journal of Cancer,2022

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. M1 macrophage-membrane-cloaked paclitaxel/β-elemene nanoparticles targeting cervical cancer for enhanced therapy;International Journal of Pharmaceutics: X;2024-12

2. Strategies for enhancing non-small cell lung cancer treatment: Integrating Chinese herbal medicines with epidermal growth factor receptor-tyrosine kinase inhibitors therapy;European Journal of Pharmacology;2024-10

3. A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib;Scientific Reports;2024-05-18

4. Advances and future perspectives of intranasal drug delivery: A scientometric review;Journal of Controlled Release;2024-03

5. The role of tetrahydrocurcumin in disease prevention and treatment;Food & Function;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3